Learning hash functions have been widely applied for large-scale image retrieval. Existing methods usually use CNNs to process an entire image at once, which is efficient for single-label images but not for multi-label images. First, these methods cannot fully exploit independent features of different objects in one image, resulting in some small object features with important information being ignored. Second, the methods cannot capture different semantic information from dependency relations among objects. Third, the existing methods ignore the impacts of imbalance between hard and easy training pairs, resulting in suboptimal hash codes. To address these issues, we propose a novel deep hashing method, termed multi-label hashing for dependency relations among multiple objectives (DRMH). We first utilize an object detection network to extract object feature representations to avoid ignoring small object features and then fuse object visual features with position features and further capture dependency relations among objects using a self-attention mechanism. In addition, we design a weighted pairwise hash loss to solve the imbalance problem between hard and easy training pairs. Extensive experiments are conducted on multi-label datasets and zero-shot datasets, and the proposed DRMH outperforms many state-of-the-art hashing methods with respect to different evaluation metrics.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TIP.2023.3251028DOI Listing

Publication Analysis

Top Keywords

dependency relations
16
multi-label hashing
8
hashing dependency
8
relations multiple
8
multiple objectives
8
existing methods
8
small object
8
object features
8
relations objects
8
hard easy
8

Similar Publications

Background: Epidemiological studies report an elevated risk of neurodegenerative disorders, particularly Parkinson's disease (PD), in patients with type 2 diabetes mellitus (T2DM) that is mitigated in those prescribed incretin mimetics or dipeptidyl peptidase 4 inhibitors (DPP-4Is). Incretin mimetic repurposing appears promising in human PD and Alzheimer's disease (AD) clinical trials. DPP-4Is are yet to be evaluated in PD or AD human studies.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Yonsei University, Incheon, Incheon, Korea, Republic of (South).

Background: Cyclin Y (CCNY) is a member of cyclin protein family inhibiting long-term synaptic plasticity, which is related to the learning and memory function in neuronal system. Recently, CCNY has been reported to associate with the cognitive deficits in Alzheimer's disease (AD).

Method: In this study, we discovered PFTAIRE peptide to diminish CCNY protein level and to ameliorate cognitive dysfunction in AD.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Sharp Therapeutics, Pittsburgh, PA, USA.

Background: Progranulin (GRN) plays a critical role in familial frontotemporal dementia (fFTD), where GRN haploinsufficiency leads to reduction in PGRN levels in the brain, resulting in degeneration of neurons in the frontal lobe of brain responsible for personality, language, and behavior. FTD is the most common dementia in people under 60. Sortilin (Sort1), expressed by neurons, endocytoses, and delivers PGRN rapidly to lysosomes for degradation.

View Article and Find Full Text PDF

Background: Alzheimer's disease (AD) is characterized by hallmark amyloid plaques and neurofibrillary tangles as well as by a significant loss of myelin in the cerebral cortex and other brain regions, which contributes to neurodegeneration and cognitive decline. Remyelination, of the myelin sheath by oligodendrocytes, is a process that may be impaired in neurodegenerative diseases. Depending on the severity of the disease, there occurs loss or partial damage of the myelin sheath surrounding the neuron leading to memory deficits.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Gachon University, Seongnam, Gyeonggido, Korea, Republic of (South).

Background: Anethum graveolans commonly known as Dill is an herb from celery family displaying anti-oxidant benefits. The present study focused on the potential of Anethum graveolans as a multifunctional curative remedy for AD treatment.

Method: Hexane (H) and ethyl acetate (EA) extracts of Dill were prepared and subjected to GC-MS for identification of important bioactive components.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!